Olvanil: A non-pungent TRPV1 activator has anti-emetic properties in the ferret

Andrews, 1993, Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret, Neuropharmacology, 32, 799, 10.1016/0028-3908(93)90189-A Andrews, 1990, The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity, Can. J. Physiol. Pharmacol., 68, 325, 10.1139/y90-047 Andrews, 2000, The development of the emetic reflex in the house musk shrew, Suncus murinus, Brain Res. Dev. Brain Res., 121, 29, 10.1016/S0165-3806(00)00022-5 Andrews, 2000, The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew, Br. J. Pharmacol., 130, 1247, 10.1038/sj.bjp.0703428 Andrews, 2004, The role of tachykinins and the tachykinin receptor in nausea and emesis, 359, 10.1007/978-3-642-18891-6_12 Appendino, 2005, Development of the first ultra-potent “capsaicinoid” agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential, J. Pharmacol. Exp. Ther., 312, 561, 10.1124/jpet.104.074864 Beltramo, 1999, Anandamide transport inhibition by the vanilloid agonist olvanil, Eur. J. Pharmacol., 364, 75, 10.1016/S0014-2999(98)00821-8 Bowser-Riley, 1990, Role of vagal afferent C fibres in the bradycardiac response to an increase in arterial blood pressure in ferrets, Exp. Physiol., 75, 859, 10.1113/expphysiol.1990.sp003470 Chahl, 1987, The acute effects of capsaicin on the cardiovascular system, Acta Physiol. Hung., 69, 413 Costall, 1990, Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret, Neuropharmacology, 29, 453, 10.1016/0028-3908(90)90167-P Darmani, 2005, Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew, Neuropharmacology, 49, 502, 10.1016/j.neuropharm.2005.04.007 Dekermendjian, 1997, The affinity to the brain dopamine D1 receptors in vitro of triprenyl phenols isolated from the fruit bodies of Albatrellus ovinus, Eur. J. Med. Chem., 32, 351, 10.1016/S0223-5234(97)89088-5 Dray, 1991, Systemic capsaicin and olvanil reduce the acute algogenic and the late inflammatory phase following formalin injection into rodent paw, Pain, 47, 79, 10.1016/0304-3959(91)90014-O Geraghty, 2002, Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide, Br. J. Pharmacol., 137, 919, 10.1038/sj.bjp.0704931 Hillard, 2007, Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase, J. Mol. Neurosci., 33, 18, 10.1007/s12031-007-0045-0 Holmes, 2009, Opportunities for the replacement of animals in the study of nausea and vomiting, Br. J. Pharmacol., 157, 865, 10.1111/j.1476-5381.2009.00176.x Iida, 2003, TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate, Neuropharmacology, 44, 958, 10.1016/S0028-3908(03)00100-X Jonassohn, 1997, The preparation and bioactivities of (-)-isovelleral, Bioorg. Med. Chem., 5, 1363, 10.1016/S0968-0896(97)00055-2 Kan, 2008, Mechanism of the TP receptor agonist U46619 for inducing emesis in the ferret. Nauyn-Schmied, Arch. Pharmacol., 378, 655, 10.1007/s00210-008-0325-4 Knox, 1993, Behavioral studies of emetic sensitivity in the ferret, Brain Res. Bull., 31, 477, 10.1016/0361-9230(93)90112-O La Rana, 2006, Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide], J. Pharmacol. Exp. Ther., 317, 1365, 10.1124/jpet.105.100792 Lau, 2005, Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret, Eur. J. Pharmacol., 516, 247, 10.1016/j.ejphar.2005.05.028 Movahed, 2005, Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation, Br. J. Pharmacol, 146, 171, 10.1038/sj.bjp.0706313 Pilowsky, 2002, Baroreceptor reflex pathways and neurotransmitters: 10 years on, J. Hypertens., 20, 1675, 10.1097/00004872-200209000-00002 Ross, 2003, Anandamide and vanilloid TRPV1 receptors, Br. J. Pharmacol., 140, 790, 10.1038/sj.bjp.0705467 Rudd, 2004, Mechanisms of acute, delayed and anticipatory vomiting in cancer and cancer treatment, 15 Rudd, 2001, Genital grooming and emesis induced by vanilloids in Suncus murinus, the house musk shrew, Eur. J. Pharmacol., 422, 185, 10.1016/S0014-2999(01)01041-X Sharkey, 2007, Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret, Eur. J. Neurosci., 25, 2773, 10.1111/j.1460-9568.2007.05521.x Shiroshita, 1997, Capsaicin in the 4th ventricle abolishes retching and transmission of emetic vagal afferents to solitary nucleus neurons, Eur. J. Pharmacol., 339, 183, 10.1016/S0014-2999(97)01370-8 Szallasi, 2001, Vanilloid receptor ligands: hopes and realities for the future, Drugs Aging, 18, 561, 10.2165/00002512-200118080-00001 Szallasi, 1996, Vanilloid receptors: new insights enhance potential as a therapeutic target, Pain, 68, 195, 10.1016/S0304-3959(96)03202-2 Szallasi, 1999, Vanilloid (Capsaicin) receptors and mechanisms, Pharmacol. Rev., 51, 159 Tattersall, 1996, Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets, Neuropharmacology, 35, 1121, 10.1016/S0028-3908(96)00020-2 Uchino, 2006, Modulation of emetic response by carotid baro- and chemoreceptor activations, Auton. Neurosci., 128, 25, 10.1016/j.autneu.2005.12.006 Wan, 2004, The emetic, hypothermic, and anti-emetic actions of centrally administered vanilloids in Suncus murinus, J. Pharmacol. Sci., 94, 96 Watson, 1995, The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor, Br. J. Pharmacol., 115, 84, 10.1111/j.1476-5381.1995.tb16324.x Xiong, 2008, Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization, Mol. Pharmacol., 73, 314, 10.1124/mol.107.039149 Yamakuni, 2002, Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets, Eur. J. Pharmacol., 442, 273, 10.1016/S0014-2999(02)01541-8 Yoshikawa, 1996, Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret, Eur. J. Pharmacol., 301, 143, 10.1016/0014-2999(96)00061-1